{"id":"metformin-continue","safety":{"commonSideEffects":[{"rate":"20–30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3–5","effect":"Metallic taste"},{"rate":"10–30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare, in renal impairment)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that primarily works by decreasing gluconeogenesis in the liver and enhancing peripheral glucose uptake and utilization. It may also improve insulin sensitivity by reducing hepatic fat content and modulating mitochondrial function. The drug does not stimulate insulin secretion, making it weight-neutral and useful across a broad range of patients.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in type 2 diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:38.768Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Prediabetes (prevention of progression to type 2 diabetes)"},{"name":"Polycystic ovary syndrome (PCOS)-related hyperglycemia"}]},"trialDetails":[{"nctId":"NCT00445627","phase":"","title":"Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-06-18","conditions":"Obesity, Overweight, Diabetes Mellitus, Type 2","enrollment":82},{"nctId":"NCT02365597","phase":"PHASE2","title":"An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2015-04-22","conditions":"Urothelial Cancer","enrollment":239},{"nctId":"NCT07226453","phase":"PHASE2","title":"Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-04","conditions":"Posterior Fossa Ependymal Tumor","enrollment":30},{"nctId":"NCT03006172","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2016-12-13","conditions":"Breast Cancer, Solid Tumor","enrollment":200},{"nctId":"NCT07291297","phase":"PHASE2","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03-04","conditions":"Sarcoma Metastatic, Sarcoma, Soft Tissue","enrollment":50},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":"Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma","enrollment":60},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT06044025","phase":"PHASE1","title":"A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2024-04-11","conditions":"Castration Sensitive Prostate Cancer","enrollment":34},{"nctId":"NCT06948825","phase":"PHASE2","title":"Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-10-27","conditions":"Weight Loss, Gestational Diabetes Mellitus in Pregnancy, Postpartum Care","enrollment":60},{"nctId":"NCT03862950","phase":"PHASE2","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2019-05-24","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked","enrollment":125},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT05313529","phase":"NA","title":"LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2022-10-08","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":396},{"nctId":"NCT05023967","phase":"PHASE2","title":"Metformin and Nightly Fasting in Women With Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-04-04","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ","enrollment":120},{"nctId":"NCT07303127","phase":"NA","title":"Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2021-06-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":80},{"nctId":"NCT04691960","phase":"PHASE2","title":"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-08","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT04414540","phase":"PHASE2","title":"Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Trisha Wise-Draper","startDate":"2020-08-31","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT05183204","phase":"PHASE2","title":"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-02-14","conditions":"Glioblastoma","enrollment":33},{"nctId":"NCT04841668","phase":"","title":"Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly","status":"RECRUITING","sponsor":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","startDate":"2021-04-10","conditions":"Type 2 Diabetes Mellitus","enrollment":136},{"nctId":"NCT07129473","phase":"PHASE2","title":"Hyperemesis Gravidarum Risk Reduction With Metformin","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-01","conditions":"Hyperemesis Gravidarum","enrollment":224},{"nctId":"NCT07274644","phase":"PHASE4","title":"Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2025-03-29","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Diabetes Mellitus Type 2","enrollment":36},{"nctId":"NCT06280274","phase":"PHASE4","title":"Metformin Use in Patients Undergoing Total Joint Replacement Surgery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-06-27","conditions":"Hyperglycemia","enrollment":40},{"nctId":"NCT04220021","phase":"PHASE2","title":"Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2020-01-10","conditions":"C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia","enrollment":41},{"nctId":"NCT07027969","phase":"PHASE4","title":"Metabolic Surgery for Atrial Fibrillation Elimination","status":"NOT_YET_RECRUITING","sponsor":"Ali Aminian","startDate":"2026-02-01","conditions":"Atrial Fibrillation, Obesity and Obesity-related Medical Conditions","enrollment":100},{"nctId":"NCT04945148","phase":"PHASE2","title":"Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide","status":"RECRUITING","sponsor":"Hopital Foch","startDate":"2024-05-10","conditions":"Glioblastoma, IDH-wildtype","enrollment":640},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT06490874","phase":"","title":"Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2025-09","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":""},{"nctId":"NCT04392284","phase":"NA","title":"Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-04-19","conditions":"Insulin Resistance, Obesity, Diabetes","enrollment":40},{"nctId":"NCT02755844","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2016-09-23","conditions":"Recurrent Endometrial Cancer","enrollment":35},{"nctId":"NCT05260021","phase":"PHASE3","title":"A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-04-13","conditions":"Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2","enrollment":99},{"nctId":"NCT01471808","phase":"PHASE4","title":"Effects of Different Early Intensive Therapies on Long-term β-cell Function","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2011-10","conditions":"Diabetes Mellitus, Type 2","enrollment":264},{"nctId":"NCT06257966","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2024-07-17","conditions":"Type2 Diabetes Mellitus","enrollment":600},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":"Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers","enrollment":60},{"nctId":"NCT05819853","phase":"PHASE3","title":"Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-11-03","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese","enrollment":80},{"nctId":"NCT05932251","phase":"","title":"Towards Precision Medicine for Diabetes in Pregnancy","status":"SUSPENDED","sponsor":"Zuyderland Medisch Centrum","startDate":"2023-06-19","conditions":"Gestational Diabetes, Gestational Diabetes Mellitus","enrollment":103},{"nctId":"NCT07092618","phase":"PHASE2, PHASE3","title":"Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation","status":"RECRUITING","sponsor":"AgelessRx","startDate":"2024-12-17","conditions":"Longevity, GLP-1, Geroscience","enrollment":150},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT05929495","phase":"PHASE2","title":"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-02-12","conditions":"Glioblastoma, IDH-wildtype, Metformin, Malignancies","enrollment":25},{"nctId":"NCT07073768","phase":"PHASE3","title":"Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Khyber Medical College, Peshawar","startDate":"2025-07-01","conditions":"Diabetes Mellitus Type 2, Glycemic Control for Diabetes Mellitus","enrollment":126},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT06682130","phase":"PHASE2","title":"Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-11-10","conditions":"Diffuse Large B-cell Lymphoma(DLBCL)","enrollment":40},{"nctId":"NCT06085703","phase":"NA","title":"Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial","status":"COMPLETED","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2024-04-01","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":24},{"nctId":"NCT04207944","phase":"PHASE2","title":"The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-07-10","conditions":"IPMN, IPMN, Pancreatic","enrollment":100},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT07001878","phase":"PHASE4","title":"Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis","status":"NOT_YET_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2025-07-01","conditions":"Psychosis, Cannabis Use","enrollment":24},{"nctId":"NCT04090580","phase":"PHASE3","title":"Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-10-27","conditions":"Type 2 Diabetes","enrollment":88},{"nctId":"NCT06942390","phase":"PHASE2","title":"Topical Metformin Versus Topical Ketotifen in Melasma Treatment","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-06-01","conditions":"Melasma","enrollment":60},{"nctId":"NCT01905046","phase":"PHASE3","title":"Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2015-11-23","conditions":"Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier","enrollment":86},{"nctId":"NCT06033131","phase":"PHASE3","title":"PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia","status":"RECRUITING","sponsor":"Lina Bergman","startDate":"2024-01-19","conditions":"Preeclampsia","enrollment":294},{"nctId":"NCT06107153","phase":"PHASE3","title":"Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control","status":"COMPLETED","sponsor":"University of Basrah","startDate":"2023-11-01","conditions":"Type2diabetes","enrollment":243},{"nctId":"NCT06452511","phase":"EARLY_PHASE1","title":"Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS","status":"COMPLETED","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2024-08-01","conditions":"PCOS","enrollment":100},{"nctId":"NCT06000462","phase":"PHASE4","title":"The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2024-04-22","conditions":"Obesity, Dapagliflozin Adverse Reaction, Weight Loss","enrollment":150},{"nctId":"NCT04809311","phase":"","title":"Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-04-30","conditions":"Diabetes Mellitus, Type 2","enrollment":156},{"nctId":"NCT06884683","phase":"PHASE2","title":"Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma","status":"TERMINATED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2020-09-17","conditions":"Metastatic Renal Cell Carcinoma","enrollment":12},{"nctId":"NCT06693934","phase":"NA","title":"Jockey Club Precision Prevention Programme on Young Onset Diabetes","status":"RECRUITING","sponsor":"Juliana CN Chan","startDate":"2024-11-23","conditions":"Diabetes, Pre Diabetes, Hypertension","enrollment":9000},{"nctId":"NCT05743907","phase":"PHASE4","title":"Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2023-04-25","conditions":"Diabetes Mellitus","enrollment":231},{"nctId":"NCT06863532","phase":"NA","title":"Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-30","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT06296836","phase":"PHASE4","title":"Effect of Continuing Versus Holding Metformin During Hospitalizations.","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-01-21","conditions":"Diabetes Mellitus, Type 2","enrollment":300},{"nctId":"NCT06045351","phase":"PHASE1","title":"Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Aga Khan University","startDate":"2024-01-01","conditions":"Anovulatory Infertility","enrollment":142},{"nctId":"NCT04275713","phase":"PHASE2","title":"Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-05-22","conditions":"Cervical Cancer","enrollment":41},{"nctId":"NCT06781775","phase":"PHASE4","title":"GDM: Insulin with or Without Metformin?","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2024-12-12","conditions":"Gestational Diabetes","enrollment":130},{"nctId":"NCT03479476","phase":"PHASE2, PHASE3","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2018-04-30","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked","enrollment":120},{"nctId":"NCT06353061","phase":"PHASE2","title":"Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-04-15","conditions":"Cervical Cancer, Radiotherapy, Metformin","enrollment":51},{"nctId":"NCT06713967","phase":"NA","title":"Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-02-02","conditions":"Polycystic Ovarian Syndrome (PCOS), Pregnancy Outcomes","enrollment":70},{"nctId":"NCT06613854","phase":"PHASE4","title":"Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":90},{"nctId":"NCT04899349","phase":"PHASE2","title":"Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-04-06","conditions":"Breast Cancer","enrollment":2},{"nctId":"NCT06247748","phase":"PHASE1","title":"Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects","status":"COMPLETED","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2023-10-19","conditions":"Diabetes Mellitus, Type 2, Overweight","enrollment":28},{"nctId":"NCT03713801","phase":"PHASE1","title":"Impact of Metformin on Immunity","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2019-01-14","conditions":"Aging, Vaccine Response Impaired","enrollment":18},{"nctId":"NCT03194945","phase":"PHASE4","title":"Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2017-11-01","conditions":"Type 2 Diabetes Mellitus","enrollment":412},{"nctId":"NCT02523898","phase":"PHASE2","title":"Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant","status":"TERMINATED","sponsor":"Semnan University of Medical Sciences","startDate":"2015-11","conditions":"Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":388},{"nctId":"NCT03503942","phase":"NA","title":"The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2017-12-30","conditions":"Pre-diabetes","enrollment":751},{"nctId":"NCT06339086","phase":"PHASE3","title":"Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Chengdu Brilliant Pharmaceutical Co., Ltd.","startDate":"2024-04","conditions":"Type 2 Diabetes Mellitus","enrollment":478},{"nctId":"NCT05702905","phase":"PHASE4","title":"Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-05-09","conditions":"PCOS (Polycystic Ovary Syndrome), Semaglutide","enrollment":75},{"nctId":"NCT04343872","phase":"NA","title":"Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-12-10","conditions":"Pre-diabetes","enrollment":36},{"nctId":"NCT03429543","phase":"PHASE3","title":"Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-03-20","conditions":"Diabetes Mellitus, Type 2","enrollment":175},{"nctId":"NCT06222476","phase":"NA","title":"Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.","status":"NOT_YET_RECRUITING","sponsor":"Yan Bi","startDate":"2024-02-20","conditions":"Diabetic Nephropathy Type 2","enrollment":106},{"nctId":"NCT06217887","phase":"NA","title":"Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2020-05-10","conditions":"Type 2 Diabetes Mellitus, Cognitive Function Abnormal","enrollment":58},{"nctId":"NCT05816057","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hangzhou Jiuyuan Gene Engineering Co. Ltd.,","startDate":"2022-07-25","conditions":"Diabetes Mellitus, Type 2","enrollment":476},{"nctId":"NCT03309007","phase":"PHASE3","title":"A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2017-09-01","conditions":"PreDiabetes, Aging","enrollment":25},{"nctId":"NCT04738799","phase":"NA","title":"The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2021-04-29","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT02140788","phase":"PHASE4","title":"Effects of Metformin and Fish Oil on Treatment With Clozapine","status":"TERMINATED","sponsor":"Duke University","startDate":"2011-05","conditions":"Schizophrenia, Schizo-affective Disorder","enrollment":34},{"nctId":"NCT06057246","phase":"NA","title":"Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2023-05-15","conditions":"Type 2 Diabetes","enrollment":144},{"nctId":"NCT03737240","phase":"PHASE3","title":"IDegLira HIGH Trial","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-01-15","conditions":"Diabetes Mellitus","enrollment":145},{"nctId":"NCT02960659","phase":"PHASE1, PHASE2","title":"Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-05-09","conditions":"Type 2 Diabetes","enrollment":24},{"nctId":"NCT05177588","phase":"PHASE4","title":"Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-07-21","conditions":"Heart Failure","enrollment":70},{"nctId":"NCT05759312","phase":"PHASE1, PHASE2","title":"Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2023-03","conditions":"Ovarian Clear Cell Carcinoma","enrollment":20},{"nctId":"NCT03135301","phase":"PHASE3","title":"Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-20","conditions":"Infertility, Female","enrollment":80},{"nctId":"NCT01485614","phase":"PHASE3","title":"Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-02-10","conditions":"Diabetes Mellitus, Type 2 Diabetes","enrollment":200},{"nctId":"NCT01131182","phase":"PHASE4","title":"Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-13","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":1147},{"nctId":"NCT04893148","phase":"PHASE4","title":"Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Chungbuk National University Hospital","startDate":"2020-05-26","conditions":"Type 2 Diabetes Mellitus, Glucose, High Blood","enrollment":40},{"nctId":"NCT04994561","phase":"PHASE1","title":"VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements","status":"WITHDRAWN","sponsor":"Vitality in Aging Research Group, Inc.","startDate":"2022-06","conditions":"Aging","enrollment":""},{"nctId":"NCT02836704","phase":"PHASE4","title":"Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-09-09","conditions":"Diabetes Mellitus, Type 2","enrollment":892},{"nctId":"NCT02941367","phase":"PHASE4","title":"Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-02-23","conditions":"Diabetes Mellitus, Type 2","enrollment":184},{"nctId":"NCT03958591","phase":"PHASE4","title":"Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification","status":"UNKNOWN","sponsor":"Yanbing Li","startDate":"2019-05-01","conditions":"Diabetes type2","enrollment":274},{"nctId":"NCT04855513","phase":"NA","title":"Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2022-03-24","conditions":"Preeclampsia, Preeclampsia Severe, High Risk Pregnancy","enrollment":414},{"nctId":"NCT04468243","phase":"NA","title":"Pilot RCT Feasibility Study: Cancer and T2D","status":"TERMINATED","sponsor":"University of Florida","startDate":"2021-04-01","conditions":"Diabetes Mellitus, Type 2, Cancer","enrollment":3},{"nctId":"NCT04356742","phase":"PHASE3","title":"Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2020-05-26","conditions":"Type 2 Diabetes","enrollment":198},{"nctId":"NCT01482286","phase":"PHASE3","title":"Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS","status":"TERMINATED","sponsor":"Pennington Biomedical Research Center","startDate":"2012-05","conditions":"Polycystic Ovary Syndrome","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":261,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metformin"],"phase":"marketed","status":"active","brandName":"Metformin continue","genericName":"Metformin continue","companyName":"University of Texas Southwestern Medical Center","companyId":"university-of-texas-southwestern-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in type 2 diabetes. Used for Type 2 diabetes mellitus, Prediabetes (prevention of progression to type 2 diabetes), Polycystic ovary syndrome (PCOS)-related hyperglycemia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}